Literature DB >> 9885932

Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive.

M R DiSiena1, R Intres, D J Carter.   

Abstract

A 34-year-old woman with a history of asthma and oral contraceptive use died suddenly. Autopsy examination showed chronic pulmonary emboli with an acute pulmonary saddle embolus. An underlying congenital thrombophilic disorder was considered. Molecular studies on DNA isolated from blood using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analysis revealed coagulation factor V Leiden mutation. The incidence of venous thromboembolism in patients with factor V Leiden mutation and associated activated protein C (APC) resistance is discussed.

Entities:  

Keywords:  Biology; Case Studies--women; Contraception; Contraceptive Methods; Diseases; Embolism; Family Planning; Hematological Effects--women; Hemic System; Oral Contraceptives; Physiology; Pulmonary Embolism--women; Research Methodology; Research Report; Studies; Thromboembolism--women; Vascular Diseases; Women

Mesh:

Substances:

Year:  1998        PMID: 9885932     DOI: 10.1097/00000433-199812000-00013

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  3 in total

1.  Short term clinical outcome of acute saddle pulmonary embolism.

Authors:  P Pruszczyk; R Pacho; M Ciurzynski; M Kurzyna; B Burakowska; W Tomkowski; A Bochowicz; A Torbicki
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

2.  [A young woman with fulminant pulmonary embolism].

Authors:  T Spinner; M Segerer; A Holub; C Spes; H Mudra
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

3.  Saddle versus non-saddle pulmonary embolism: differences in the clinical, echocardiographic, and outcome characteristics.

Authors:  Wanis H Ibrahim; Shaikha D Al-Shokri; Musa S Hussein; Antoun Kamel; Lana M Abu Afifeh; Gowri Karuppasamy; Jessiya V Parambil; Farras M Elasad; Mohamed S Abdelghani; Ahmed Abdellah; Mohammed E Faris
Journal:  Libyan J Med       Date:  2022-12       Impact factor: 1.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.